Migraine Relief

Description

IBUPROFEN CAPSULES are formulated as softgels containing 200 mg of ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID) indicated for pain relief. Each bottle contains 80 liquid-filled capsules. The product is identified by the National Drug Code (NDC) 0363-0240-78. This formulation is comparable to the active ingredient found in Advil Migraine. The actual size of the softgels is indicated on the packaging.

Uses and Indications

This drug is indicated for the acute treatment of migraine in adults. There are no known teratogenic or nonteratogenic effects associated with its use.

Dosage and Administration

Patients should adhere strictly to the recommended dosage and not exceed the directed amount. The smallest effective dose should be utilized to achieve the desired therapeutic effect.

For adults, the recommended dosage is to take 2 capsules with a full glass of water. If symptoms persist or worsen, patients are advised to consult their healthcare provider. It is important to note that no more than 2 capsules should be taken within a 24-hour period unless otherwise directed by a physician.

For individuals under 18 years of age, it is essential to seek guidance from a healthcare professional before administration.

Contraindications

Use is contraindicated in patients with a history of allergic reactions to any other pain reliever or fever reducer. Additionally, administration is contraindicated immediately before or after heart surgery due to potential complications associated with surgical recovery.

Warnings and Precautions

Ibuprofen may induce severe allergic reactions, particularly in individuals with a known allergy to aspirin. Symptoms indicative of an allergic response may include hives, facial swelling, asthma (wheezing), shock, skin reddening, rash, and blisters. In the event of an allergic reaction, it is imperative to discontinue use immediately and seek medical assistance.

The use of this product, which contains a nonsteroidal anti-inflammatory drug (NSAID), carries a significant risk of severe stomach bleeding. This risk is notably elevated in patients who are 60 years of age or older, have a history of stomach ulcers or bleeding disorders, are concurrently using anticoagulants or steroid medications, are taking other NSAIDs (including aspirin, ibuprofen, or naproxen), consume three or more alcoholic beverages daily while using this product, or exceed the recommended dosage or duration of use.

Additionally, NSAIDs, excluding aspirin, are associated with an increased risk of heart attack, heart failure, and stroke, which can be fatal. The likelihood of these adverse events is heightened when the medication is used in excess of the recommended dosage or for prolonged periods.

Healthcare professionals should be aware that the occurrence of medication overuse headaches may arise if this product is utilized for ten or more days within a month.

In cases of overdose, immediate medical attention is required. Healthcare providers should advise patients to contact a Poison Control Center or seek emergency medical help without delay.

Patients should be instructed to discontinue use and consult a physician if they experience any signs of stomach bleeding, which may manifest as feeling faint, vomiting blood, passing bloody or black stools, or experiencing persistent stomach pain. Furthermore, symptoms indicative of heart problems or stroke, such as chest pain, difficulty breathing, unilateral weakness, slurred speech, or leg swelling, warrant immediate medical evaluation. If migraine headache pain is not alleviated or worsens following the initial dose, or if any new symptoms arise, patients should seek medical advice promptly.

Side Effects

Patients using ibuprofen should be aware of several serious and common adverse reactions associated with its use.

Severe allergic reactions may occur, particularly in individuals with a known allergy to aspirin. Symptoms of such reactions can include hives, facial swelling, asthma (wheezing), shock, skin reddening, rash, and blisters.

The use of ibuprofen, as a nonsteroidal anti-inflammatory drug (NSAID), carries a risk of severe stomach bleeding. This risk is heightened in patients who are 60 years of age or older, have a history of stomach ulcers or bleeding problems, are taking anticoagulants or steroid medications, consume three or more alcoholic drinks daily, or use other NSAIDs concurrently.

Additionally, NSAIDs, excluding aspirin, have been associated with an increased risk of heart attack, heart failure, and stroke, which can be fatal. This risk is particularly pronounced in patients who exceed the recommended dosage or duration of use.

Patients should discontinue use and seek medical attention if they experience signs of stomach bleeding, such as feeling faint, vomiting blood, having bloody or black stools, or persistent stomach pain. Symptoms indicative of heart problems or stroke, including chest pain, difficulty breathing, unilateral weakness, slurred speech, or leg swelling, also warrant immediate medical consultation. Furthermore, if migraine headache pain is not alleviated or worsens after the first dose, or if any new symptoms arise, patients should contact their healthcare provider.

It is advised that patients consult a doctor before using ibuprofen if they have never had migraines diagnosed by a healthcare professional, experience headaches that differ from their usual migraines, have the worst headache of their life, present with fever and stiff neck, or have headaches that began after a head injury, exertion, coughing, or bending. Additional caution is warranted for those who have experienced their first headache after age 50, have daily headaches, or have migraines severe enough to require bed rest.

Patients with a history of stomach problems, high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or a previous stroke should also seek medical advice prior to use. It is important to inform healthcare providers about any other medications being taken, particularly if aspirin is being used for heart attack or stroke prevention, as ibuprofen may diminish the effectiveness of aspirin in this context.

Drug Interactions

Ibuprofen may diminish the cardioprotective effects of aspirin when aspirin is used for the prevention of heart attack or stroke. It is advisable for patients to consult their healthcare provider regarding the concurrent use of these medications to ensure optimal therapeutic outcomes. Monitoring for cardiovascular efficacy may be warranted in patients who require both medications.

Packaging & NDC

Below are the non-prescription pack sizes of Migraine Relief (ibuprofen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 18 years of age should consult a healthcare professional before use. It is important to assess the appropriateness of treatment and dosage for this population, as specific recommendations may vary based on individual health needs and conditions.

Geriatric Use

Elderly patients, particularly those aged 60 and older, are at an increased risk for severe stomach bleeding. Therefore, it is crucial for healthcare providers to exercise caution when prescribing this medication to geriatric patients.

To minimize the risk of adverse effects, it is recommended that elderly patients take the smallest effective dose and adhere strictly to the directed dosage. Monitoring for signs of gastrointestinal bleeding is advised, given the heightened vulnerability of this population. Careful consideration of these factors can help ensure the safe use of the medication in elderly patients.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional before using this medication. It is particularly important to avoid the use of ibuprofen after 20 weeks of pregnancy unless specifically directed by a physician, as it may pose risks to the developing fetus and lead to complications during delivery. Healthcare providers should carefully consider the potential benefits and risks when prescribing this medication to pregnant patients, especially in the later stages of pregnancy.

Lactation

Lactating mothers are advised to consult a health professional before using this medication while breastfeeding. It is particularly important to avoid the use of ibuprofen at 20 weeks of gestation or later unless specifically directed by a physician, as it may pose risks to the unborn child or lead to complications during delivery. There is no specific data provided regarding the excretion of ibuprofen in breast milk or its effects on breastfed infants. Therefore, healthcare providers should weigh the potential benefits against the risks when considering this medication for lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from excessive dosing. Symptoms of overdosage can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide further management and intervention strategies.

Documentation of the incident, including the amount ingested and the time of exposure, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

It is especially important not to use ibuprofen at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor, as it may cause problems in the unborn child or complications during delivery. No specific non-teratogenic effects or additional nonclinical toxicology details are available in the provided data. Furthermore, there are no specific findings related to animal pharmacology and toxicology.

Postmarketing Experience

Postmarketing experience has identified several adverse reactions reported voluntarily or through surveillance programs. These include allergic reactions such as hives, facial swelling, asthma (wheezing), shock, skin reddening, rash, and blisters. Additionally, cases of stomach bleeding have been noted, particularly in patients aged 60 years or older, those with a history of stomach ulcers or bleeding problems, individuals taking blood thinners or steroids, those consuming three or more alcoholic drinks daily, or patients exceeding the recommended dosage.

There is also an increased risk of heart attack, heart failure, and stroke associated with prolonged use or higher doses of the medication. Furthermore, medication overuse headache has been reported, which may exacerbate if the product is used for 10 or more days per month.

Patient Counseling

Patients should be advised to seek immediate medical assistance or contact a Poison Control Center in the event of an overdose. It is recommended that patients take the medication with food or milk if they experience stomach upset.

Healthcare providers should encourage patients to consult a doctor before using the medication if they have never had migraines diagnosed by a health professional. Additionally, patients should be instructed to seek medical advice if they experience a headache that differs from their usual migraines, if they have the worst headache of their life, or if they present with fever and a stiff neck.

Patients should also be advised to consult a doctor before use if they have headaches that begin after or are caused by head injury, exertion, coughing, or bending. It is important to inform patients that they should seek medical advice if they experience their first headache after the age of 50, if they have daily headaches, or if they have a migraine so severe that it requires bed rest.

Healthcare providers should remind patients to ask a doctor before use if they have a history of stomach problems, such as heartburn, or if the stomach bleeding warning applies to them. Patients with high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or a history of stroke should also be advised to consult a doctor prior to use.

Furthermore, patients taking a diuretic or under a doctor's care for any serious condition should be encouraged to discuss their situation with a healthcare professional before using the medication. It is also essential to inform patients that they should consult a doctor or pharmacist if they are taking aspirin for heart attack or stroke, as ibuprofen may diminish the benefits of aspirin. Lastly, patients should be advised to speak with a doctor or pharmacist before use if they are taking any other medications.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available upon request. It should be stored at a temperature range of 20° to 25°C (68° to 77°F). Care must be taken to avoid exposure to excessive heat, specifically temperatures above 40°C (104°F). Additionally, the product must be protected from light to maintain its integrity and efficacy.

Additional Clinical Information

The route of administration for the medication is oral. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. It is particularly crucial to avoid ibuprofen after 20 weeks of pregnancy unless specifically directed by a physician, as it may pose risks to the unborn child or lead to complications during delivery.

Drug Information (PDF)

This file contains official product information for Migraine Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)